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Background: Evidence-based chronic disease prevention (EBCDP) effectively reduces
incidence rates of many chronic diseases, but contextual factors influence the
implementation of EBCDP worldwide. This study aims to examine the following
contextual factors across four countries: knowledge, access, and use of chronic disease
prevention processes.
Methods: In this cross-sectional study, public health practitioners (N = 400) from
Australia (n = 121), Brazil (n = 76), China (n = 102), and the United States (n = 101)
completed a 26-question survey on EBCDP. One-way ANOVA and Pearson’s Chi-Square
tests were used to assess differences in contextual factors of interest by country.
Results: Practitioners in China reported less knowledge of EBCDP processes
(p < 0.001) and less use of repositories of evidence-based interventions, than those from
other countries (p < 0.001). Academic journals were the most frequently used method
for accessing information about evidence-based interventions across countries. When
selecting interventions, Brazilian and Chinese practitioners were more likely to consider
implementation ease while the Australian and United States practitioners were more likely
to consider effectiveness (p < 0.001).
Conclusions: These findings can help inform and improve within and across country
strategies for implementing EBCDP interventions.
Keywords: evidence-based practice, prevention, chronic disease, knowledge, public health
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INTRODUCTION

empirical literature; China and Brazil have far less EBCDP
literature than Australia and the United States [(13, 18–22)).
There is also wide variation in relevant contextual factors across
the four countries (e.g., political and economic structures), and
they hold positions as thought leaders in their respective regions
of the world (23–26).

Chronic diseases are an increasing threat to the health and wellbeing of individuals and communities in middle- and highincome countries (1), and pose many challenges, including
reduced quality of life and productivity (2). Further, the majority
of premature deaths worldwide are due to chronic disease, and
nearly 80% of chronic disease-related mortality occurs in middleincome countries (3, 4).
Similar to evidence-based medicine, evidence-based public
health (EBPH), more specifically, evidence-based chronic disease
prevention (EBCDP) has proven to be an effective set of processes
for reducing the burden of chronic disease. These processes
may vary, but include ensuring that decision-makers have upto-date scientific evidence about the chronic disease prevention
policies and programs that are effective at improving chronic
disease health outcomes, using that evidence to inform health
and policy agendas, and considering the environments and
contextual circumstances likely to impact the application of
chronic disease prevention evidence (5–7). When EBCDP is
applied, it can prevent many cases of morbidity and mortality
due to chronic disease (8). However, the implementation of
evidence-based interventions can vary across countries due
to economic, political, structural, and sociological contextual
factors (9). Studies conducted in high-income countries (e.g.,
Australia, Canada, and the United States) have shown that
knowledge of EBCDP processes, and access to evidence-based
interventions, positively influence the implementation of EBCDP
(10). However, there is a lack of evidence-base regarding these
fundamental factors (i.e., knowledge, access, use) in middleincome countries, and how these factors compare with EBCDP
in high-income countries. More research is needed to better
understand how knowledge of EBCDP processes and access
to evidence-based interventions may vary across middle- and
high-income countries, to inform and improve future strategies
for implementing EBCDP interventions and reducing chronic
diseases worldwide (11–14).
The objective of this study is to begin to describe similarities
and differences in knowledge of EBCDP processes, avenues
for accessing information about evidence-based interventions,
factors that influence decision-making regarding planning
and implementing evidence-based programs, and use of
evidence-based repositories and quality improvement processes
across Australia, Brazil, China, and the United States. For
this study, EBCDP repositories are considered collections
of evidence-based, chronic disease-related interventions (e.g.,
Guide to Community Preventive Services in the United States,
Health-Evidence.org in Canada, Cochrane Collaboration in all
countries). Likewise, quality improvement processes are defined
as ongoing, formal assessments of the effectiveness and quality of
public health chronic disease prevention efforts (15).
For several reasons, Australia, Brazil, China, and the
United States were chosen as the countries of interest for this
study. First, they have a high prevalence of chronic diseases (e.g.,
these four countries are estimated to contribute to 32.9% of the
total global burden of cancer) (16, 17). Additionally, these four
countries have notably different levels of peer-reviewed EBCDP
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MATERIALS AND METHODS
In this cross-sectional study, public health practitioners
(N = 400) from Australia (n = 121), Brazil (n = 76), China
(n = 102), and the United States (n = 101) completed a 26question survey on EBCDP implementation. Seven questions
from this survey were used in this analysis (see Appendix). This
survey was conducted to assess contextual factors that influence
the implementation of EBCDP in Australia, Brazil, China, and
the United States. The 26-question survey was informed by
the following: the development of a guiding framework based
on previous work of the research team (27, 28); a literature
review of EBCDP measures to identify relevant questions and
gaps (2, 27, 29–33); and semi-structured interviews of public
health practitioners working in chronic disease prevention in
Australia (n = 13), Brazil (n = 9), China (n = 16), and the
United States (n = 12). Drafts of the survey were reviewed by
13 chronic disease prevention researchers, and were translated
forward and backward to Chinese and Portuguese from English.
The survey was also pilot-tested in each country to ensure
contextual appropriateness. Seven response items were deemed
non-applicable for China contexts, but were included in the
survey for the other three countries.
The team members in each country recruited public health
practitioners working in chronic disease prevention, primarily
on the local and regional levels, in each of the four countries,
to complete the survey. Convenience samples of practitioners
were identified through national databases and networks of
chronic disease prevention practitioners between November
2015 and April 2016, and recruitment took place via phone
and email. For public databases, permission was not requested,
but for networks and databases where permission was required,
it was obtained. All surveys were delivered by an email
embedded link and completed electronically. Upon completion
of the survey, all respondents were asked to re-take the
survey 2–3 weeks later for test-retest reliability testing purposes,
which was repeated until each survey respondent had been
contacted twice, with a request to retake the survey. The survey
assessed five stages of dissemination (i.e., innovation, awareness,
adoption, implementation, and maintenance), five levels of
contextual factors (i.e., individual, organizational, community,
sociocultural, and political/economic factors), and demographic
information of the practitioners (27, 28). Public health systems
across the four sampling frames varied so greatly that there was
no directly equivalent sampling method that fit the context of all
four countries, and thus response rates varied across countries.
Australia’s response rate was 18%, Brazil’s was 46%, China’s was
87%, and the United States’ was 58%. All practitioners provided
informed consent before beginning the survey. This study was
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demographic characteristics. One-way ANOVA was conducted
for the question with a 5-point Likert scale (EBCDP Knowledge),
and Pearson’s Chi-Square test was employed for questions with
four or fewer response options (Access, Decision-Making, Use
of Repositories, and Use of Quality Improvement Processes).
The Shapiro-Wilk test was performed to determine normality
of the five-level variables, and the Kruskal-Wallis test was used
as an alternative to ANOVA if the assumption of normality was
violated (35).

approved by the Washington University Institutional Review
Board, and the research ethics committees at The University of
Melbourne, Pontifical Catholic University of Parana, and Hong
Kong Polytechnic University.

Survey Questions
Level of knowledge on evidence-based processes was assessed
with the following definition and question, “Evidence-based
public health is defined as: The process of integrating sciencebased interventions with community preferences to improve
the health of populations. With this definition in mind,
how knowledgeable are you with evidence-based processes?”
with response options including, not at all knowledgeable,
slightly knowledgeable, somewhat knowledgeable, moderately
knowledgeable, and extremely knowledgeable.
The channels that participants used for accessing evidencebased interventions were assessed by asking “Which avenues do
you use to learn about the current study findings on evidencebased interventions?” The following question was asked to
assess which avenues practitioners would like more access to,
“For which avenues would you like additional access?” Both
questions had the same list of response options. Respondents
were prompted to select all response options that apply.
Factors that influence decision-making were measured by
the question, “When you make decisions about such things as
program planning and implementation, which of the following
are important to you?” Respondents were given a list of 12
possible factors, and prompted to select the top three that were
most influential in their decisions to select an intervention.
Use of repositories by self and other staff at respondents’
workplace was assessed by defining repositories and asking
practitioners to complete the two versions of this statement,
“I/Staff have used repositories to find evidence-based
interventions. . . ” The following response options included,
in none of my/their programmatic areas, in a few of my/their
programmatic area, in many of my/their programmatic areas,
in all of my/their programmatic areas, I don’t know, and not
applicable.
Use of quality improvement processes by staff at the
respondents’ workplaces was assessed by defining quality
improvement processes and asking practitioners to complete the
following statement, “Staff at my agency use quality improvement
processes...” Response options included, in none of my/their
programmatic areas, in a few of my/their programmatic areas,
in many of my/their programmatic areas, in all of my/their
programmatic areas, I don’t know, and not applicable. In Table 2,
we present a truncated version of the survey results, where we
calculated a weighted average for questions that were scalable,
and presented the top response for categorical, non-scalable
questions. The full list of questions included in this analysis, and
subsequent results, can be found in Appendix. See Table 3 for the
full list of the 26-question survey, including those not included in
the analysis for this study.

RESULTS
Across the four countries, 400 public health practitioners
working in chronic disease prevention completed the survey
(Table 1). Most of the practitioners from Australia, Brazil, and
the United States worked in local health departments, whereas
the majority of practitioners from China were physicians,
and worked in community hospitals. Across all countries, the
majority of practitioners were female (66–88%). Practitioners
were younger in Australia and China than in Brazil and the
United States. In Australia, Brazil, and the United States, most
practitioners had a Master’s degree or higher (36–57%). Australia
had the largest percentage of practitioners (42%) working
at organizations with more than 400 employees, while the
United States had the largest percentage (57%) of practitioners
working at organizations with 100 or fewer employees.

TABLE 1 | Descriptive statistics of the study sample of chronic disease prevention
practitioners in Australia, Brazil, China, and the United States, 2015–2016,
N = 400.
Variable

Brazil
n(%)

China
n(%)

United States
n(%)

Total n

121

76

102

101

Female

107(88)

50(66)

71(70)

88(88)

AGE
21–29

25(21)

6(8)

22(22)

7(7)

30–39

40(33)

28(37)

58(57)

22(22)

40–49

18(15)

23(30)

11(12)

29(30)

50–59

25(21)

16(21)

4(4)

29(30)

≥60

13(11)

3(4)

0(0)

11(11)

DEGREE
Doctorate

17(14)

3(4)

0(0)

7(7)

Master’s

51(43)

24(32)

24(24)

49(49)

Bachelor’s

36(30)

17(23)

70(69)

28(28)

Other

16(13)

31(41)

8(7)

16(16)

NUMBER OF WORKPLACE EMPLOYEES
0–100

43(38)

27(38)

10(10)

57(57)

101–400

23(20)

20(28)

66(67)

25(25)

>400

48(42)

24(34)

22(22)

18(18)

SIZE OF JURISDICTION SERVED

Analyses
All analyses were performed using SPSS version 23 (34).
Descriptive statistics were performed to determine participant
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Australian
(%)

3

0–49,999

30(28)

20(29)

5(6)

24(24)

50,000–99,999

11(10)

7(10)

10(12)

25(25)

100,000–399,999

22(21)

19(28)

50(60)

26(26)

>400,000

43(41)

22(32)

19(23)

24(24)
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TABLE 2 | Knowledge, use, and access related to evidence-based interventions in Australia, Brazil, China, and the United States in 2015–2016 (short version).
Variable

Australia (n = 121)

Brazil (n = 76)

China (n = 102)

United States (n = 101)

P-value

3.84 ± 0.8

3.71 ± 0.9

2.59 ± 1.0

4.05 ± 0.8

<0.001

63(62%)

<0.001

Knowledge of evidence-based chronic disease prevention
processes (M ± SD)

TOP FACTOR INFLUENCING DECISION-MAKING ABOUT PROGRAM PLANNING AND IMPLEMENTATION
Support from leadership at my agency

64(63%)

Available resources (program dollars and staff)
Evidence regarding the effectiveness of the intervention

69(91%)

<0.001

89(74%)

<0.001

Weighted average extent of use of repositories to find
evidence-based interventions

64%

77%

47%

65%

<0.001

Weighted average extent of other workplace staff who use
repositories to find evidence-based interventions

25%

66%

42%

54%

<0.001

Weighted average extent of other workplace staff who use
quality improvement processes

69%

63%

49%

64%

<0.001

TOP AVENUE USED TO ACCESS EVIDENCE-BASED INTERVENTIONS
Academic journals

107(88%)

57(56%)

Conferences

<0.001
70(70%)

Internet search engines

<0.001

43(57%)

<0.001

42(55%)

<0.001

TOP AVENUE FOR WHICH ADDITIONAL ACCESS IS NEEDED
Academic journals

42(40%)

0.06

Conferences
Evidence-based repositories

38(37%)

Knowledge of Evidence-Based Processes

0.12

Brazilian practitioners highlighted their desire for additional
access through conferences (p < 0.001), and practitioners
in China cited a need for additional access to Internet
search engines (p = 0.001) and Facebook (p < 0.001) more
frequently compared with practitioners from the other
countries.

Differences in knowledge of evidence-based processes, and use of
and access related to evidence-based interventions, are outlined
in Table 2 and Appendix. Mean self-assessed knowledge of
evidence-based processes differed significantly across countries.
On average, practitioners from China reported less knowledge
compared with practitioners from Australia, Brazil, and the
United States (Mean = 2.59, 3.84, 3.71, and 4.05 respectively,
p < 0.001).

Evidence-Based Decision-Making
When asked to consider factors that influence their decisionmaking when planning and implementing evidence-based
programs, practitioners from Brazil and China were more
likely to report making decisions based on leadership
(p < 0.001), elected officials (p < 0.001), and ease of intervention
implementation (p < 0.001) compared with American and
Australian counterparts. Practitioners from China were
significantly less likely to make decisions based on the evidence
regarding effectiveness of the interventions (p < 0.001), whereas
for practitioners from Australia and the United States, evidence
was commonly considered (74 and 61% respectively). In Brazil,
practitioners were more likely than those from the other three
countries to make decisions based on support from community
partnerships (p = 0.001), recommendations from funding
agencies (p < 0.001), whether their colleagues are using the
intervention (p < 0.001), available resources (p < 0.001), health
planning tools (p < 0.001), the relevance of the intervention to
the population of interest (p < 0.001), and the seriousness of the
health problem (p < 0.001).

Access to Evidence-Based Interventions
Academic journals, conferences, evidence-based repositories,
the Internet, partnerships, and trainings were among the
most frequently used avenues for accessing evidence-based
interventions across all countries. Practitioners from China
reported significantly less frequent use of most of the avenues
including the Internet, government reports, and government
staff relative to all other countries (p < 0.001). Compared
with both Brazil and China, practitioners in Australia and the
United States were significantly more likely to use email alerts,
networks, and technology-based avenues including webinars and
listservs/email newsletters/online forums (each significant at
p < 0.001).
When practitioners were asked about avenues to which they
needed additional access, the most frequently reported avenues
across all four countries included academic journals, conferences,
email alerts, evidence-based repositories, partnerships, and
training/workshops/meetings within the agency. However,
for avenues that practitioners needed additional access to,
approximately half were not significantly different across
the four countries. Practitioners in Australia requested
increased access to professional networks (p = 0.001) more
frequently than those from the other countries. Similarly,
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32(35%)

Use of Evidence-Based Repositories and
Quality Improvement Processes
There was a significant difference in the use of evidencebased repositories and quality improvement processes among
practitioners across countries. Specifically, the majority of

4

August 2018 | Volume 6 | Article 214

DeRuyter et al.

Comparing Knowledge, Accessibility, and Use

TABLE 3 | Factors influencing the dissemination and implementation of evidence-based chronic disease prevention across four countries: an assessment tool.
Questions

Response options

AWARENESS
• Evidence-based public health is defined as: “the process of integrating science-based
interventions with community preferences to improve the health of populations” (8).
1. With this definition in mind, how knowledgeable are you with evidence-based
processes? (select one)

•
•
•
•
•

Not at all knowledgeable
Slightly knowledgeable
Somewhat knowledgeable
Moderately knowledgeable
Extremely knowledgeable

Definition: Evidence-based interventions are those that several studies have found to be
effective at preventing chronic disease. Repositories are collections of evidence-based
interventions [e.g., Guide to Community Preventive Services) (US), Health-Evidence.org
(Australia), Cochrane Collaboration (US, Australia)].
2. I have used repositories to find evidence-based interventions: (select one)

•
•
•
•

in none of my programmatic areas
in a few of my programmatic areas
in many of my programmatic areas
in all of my programmatic areas

3. Staff at my agency use repositories of evidence-based interventions: (select one)

•
•
•
•

in none of my programmatic areas
in a few of my programmatic areas
in many of my programmatic areas
in all of my programmatic areas

4. When you make decisions about such things as program planning and implementation,
policy development, or funding, which of the following are important to you? (select the
top three)

•
•
•
•
•
•
•
•
•
•
•
•
•

Support from leadership at my agency
Support from elected officials
Support from community partnerships
Recommendations from the funding agency
Colleagues are using the intervention
Available resources (program dollars and staff)
How easy the intervention or policy is to implement
Evidence regarding the effectiveness of the intervention
Health planning tools (e.g., MAPP or Health People 2010)
Relevance of the intervention to the population of interest
Seriousness of the health problem
Other, please specify ______
Not applicable

5. What avenues do you use to learn about the current study findings on evidence-based
chronic disease prevention interventions? (select all that apply)

•
•
•
•
•
•
•
•
•
•
•
•
•

Academic journals
Conferences
Email alerts
Evidence-based repositories
Facebook
Funders a
Government agency staff
Government reports
Internet search engines
Listservs/Newsletters/Online forums
Media campaigns/Media interviews
Networks
Partnerships (e.g., with universities, health departments,
professional associations)
Policy briefsa
Press releases
Stakeholdersa
Technical assistance/Data liaison
Trainings/Workshops/Meetings within my agency
Webinars
Other, please specify ______
None

ADOPTION

•
•
•
•
•
•
•
•
6. For which avenues would you like additional access? (select all that apply)

Same responses as #13

IMPLEMENTATION
7. Approximately what percentage of programs supported by your agency would you say
are evidence-based?

Fill in the blank 0–100%

8. As you think about the future, what is one thing you would change to help you
implement evidence-based chronic disease prevention interventions?

Fill in the blank

(Continued)
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TABLE 3 | Continued
Questions

Response options

MAINTENANCE
Quality improvement (QI) refers to ongoing formal assessments of the effectiveness and
quality of public health chronic disease prevention efforts. (15).
Some examples of quality improvement processes include: Results-based accountability
(RBA), Community Health Improvement Plan (CHIP), Plan-Do-Study-Act (PDSA), and
Plan-Do-Check-Act.
9. Staff at my agency use quality improvement processes: (select one)

•
•
•
•

10. In your opinion, how often do programs end that should have continued? (i.e., end
without warrant) (select one)

• Never
• Sometimes
• Often

11. When you think about public health programs that have ended, what are the most
common reasons for programs ending? (Select the top three)

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

12. In your opinion, how often do programs continue that should have ended? (i.e.,
continue without warrant) (select one)

• Never
• Sometimes
• Often

13. When you think about public health programs that continued that should have ended,
what are the most common reasons for their continuation? (i.e., continue without
warrant) (Select the top three)

•
•
•
•
•
•
•
•
•
•
•
•
•
•

Program was never evaluated
Sustained support from leaders in your agency
Sustained support from the general public
Sustained support from policymakers
Prohibitive costs of starting something new
Absence of alternative options
Sustained funding
Presence of a program champion
Program was considered evidence-based
Program was low-cost
Program was easy to maintain
Other, please specify ______
I do not know
Not applicable

•
•
•
•
•
•
•
•
•
•

Not being an expert on relevant issues
Lack of confidence in finding data and statistics
Lack of skills to develop evidence-based interventions
Lack of confidence in carrying out evidence-based interventions
Lack of decision-making authority
Low value of evidence-based approaches
Workload is too heavy/not enough time
Overwhelmed by task
Other, please specify ______
None

in none of my programmatic areas
in a few of my programmatic areas
in many of my programmatic areas
in all of my programmatic areas

Program was never evaluated
Program was evaluated but did not demonstrate impact
Opposition/lack of support from leaders in my agency
Opposition/lack of support from the general public
Opposition/lack of support from policy makers
Funding diverted to a higher priority program
Grant funding ended
Change in political leadership
Insurance funding/coverage ended
Program was adopted or continued by other organizations
A program champion departed
Program was not evidence-based
Program was expensive
Program was challenging to maintain
Other, please specify ______
I do not know
Not applicable

CONTEXTUAL FACTORS
14. Which of the following are personal barriers that make it harder for you to select and
implement evidence-based chronic disease prevention interventions? (Select all that
apply)

(Continued)
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TABLE 3 | Continued
Questions

Response options

15. Which of the following are agency-level barriers that make it harder for you to select
and implement evidence-based chronic disease prevention interventions? (Select all
that apply)

•
•
•
•
•
•
•
•
•
•
•

16. Which of the following are community-level barriers that make it harder for you to
select and implement evidence-based chronic disease prevention interventions?
(Select all that apply)

• Lack of access to repositories/databases of scientific studies
• Lack of partnership between agency and community
• Community members’ needs compete with evidence-based
recommendations
• Catering to preferences of funders a
• Low priority placed on chronic disease prevention
• Other, please specify ______
• None

17. Which of the following are sociocultural barriers that make it harder for you to select
and implement evidence-based chronic disease prevention interventions? (Select all
that apply)

• Distrust of scientific data in the populations served
• Community cultural practices conflict with evidence-based
recommendations
• Not enough relevant evidence for populations served
• Serving a rural setting where data are lacking a
• Serving a highly disadvantaged population
• Serving a population that speaks a language different from the
majority a
• Evidence is presented in a language I do not understand
• Other, please specify ______
• None

18. Which of the following are political/economic barriers that make it harder for you to
select and implement evidence-based chronic disease prevention interventions?
(Select all that apply)

• Political leaders not providing enough support
• Funding changes that occur with changes in political leadership
• Political climate conflicts with evidence-based chronic disease
prevention recommendations
• Health care system does not support evidence-based chronic disease
prevention
• Other, please specify ______
• None

19. For which of the following skills would you like additional technical support or training?
(Check all that apply)

• Prioritizing program and policy options
• Quantifying the public health issue using descriptive epidemiology
(e.g., concepts of person, place, time)
• Using quantitative evaluation approaches (e.g., surveillance or
surveys)
• Using qualitative evaluation approaches (e.g., focus groups, key
informant interviews)
• Developing an action plan for achieving goals
• Defining the health issue according to the community’s needs and
assets
• Adapting interventions for different communities and settings
• Using economic data in the decision making process
• Communicating research to policy makers
• Other, please specify ________
• None

Poor understanding of evidence-based approaches
Culture/climate is not supportive of change/new ideas
No existing policies to support evidence-based approaches
Agency does not provide training in evidence-based approaches
Staff/leaders lack formal training in evidence-based approaches
Lack of access to resources (e.g., computer, Internet)
Not enough funding
Low priority placed on chronic disease prevention
No systems to ensure interventions are evidence-based
Not enough staff
Beliefs that evidence-based interventions are too difficult to
implement/sustain
• Other, please specify ______
• None

INDIVIDUAL AND AGENCY CHARACTERISTICS
20. What is your gender? (select one)

•
•
•
•

Male
Female
Other
Prefer not to answer
(Continued)
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TABLE 3 | Continued
Questions

Response options

21. What is your age? (select one)

•
•
•
•
•
•

21–29
30–39
40–49
50–59
60 and over
Prefer not to answer

22. What degree/credentials do you hold? (Check all that apply)

•
•
•
•
•
•
•
•
•
•
•
•

BS/BA
CHES
Certified Health Educator (in Diabetes, Asthma, etc.)
RN or RD
MS or MSc
MPH or MSPH
MA
Other Master’s degree
NP
MO or DO
Ph.D., Dr.PH, ScD
Other, please specify ______

23. Though you may work in several capacities, how do you best describe your primary
position? (select one)

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Academic Researcher
Academic Educator
Community Health Nurse
Department Head
Division or Bureau Head/ Division Deputy
Director
Epidemiologist
Health Educator
Nutritionist/ Dietician
Physician
Program Manager/Administrator/Coordinator
Program Planner/ Evaluator
Public Health Specialist
Social Worker
Statistician
Other, please specify ______

24. The agency in which I work has the following number of employees. (select one)

•
•
•
•
•
•
•

0–50
51–100
101–200
201–400
401–800
>800
I do not know

25. The size of the population my agency serves is has the following number of people.
(select one)

•
•
•
•
•
•
•
•
•
•

0–24,999
25,000–49,999
50,000–74,999
75,000–99,999
100,000–149,999
150,000–199,999
200,000–299,999
300,000–399,999
400,000+
I do not know

26. Is there anything else you would like to share on the topic of evidence-based chronic
disease prevention? Please specify.

• Fill in the blank

a This

item was not applicable and not included in the survey for respondents in China.

DISCUSSION

practitioners in China reported repository use and use of
quality improvement processes in few or no programmatic areas,
whereas the majority of practitioners in all three other countries
reported repository use in many or all programmatic areas
(p < 0.001).
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knowledge of their colleagues’ use of repositories. Further, highincome countries were more likely to employ avenues that
required previous knowledge of EBCDP and where to find
information about it, such as email alerts and online resources.
Using networks as a primary source for identifying evidencebased interventions implies that the individuals in Australia
that make up that network are valuable resources for such
information.
The two middle-income countries were more likely to value
ease of intervention implementation when making decisions,
which similarly could be a result of a less established commitment
to EBCDP and fewer resources dedicated to this area. Similarly,
China was less likely to consider the evidence regarding
effectiveness of interventions when making decisions, which
also aligns with their higher value on ease of implementation.
This contrasts with the two high-income countries who placed
high value on effectiveness of intervention and low value on
ease of intervention. One potential explanation is that evidence
bases produced in other countries, such as the United States,
might not be applicable or transferable to countries like China,
making the research base, regardless of its size, of low value
to Chinese practitioners. Further, this finding may reflect the
systems and policies set up for supporting and/or requiring
evidence-based interventions in high-income countries (e.g.,
funders and administrators requiring the use of evidencebased interventions, access to evidence, etc.). For example, in a
United States study mapping the landscape of behavioral health
interventions, it was found that funders of such interventions
required 75% of all money spent by a program funded under the
initiative be spent on evidence-based programming (45). If using
evidence-based interventions is not required, then choosing ease
of intervention would make logical sense in middle-income
countries.
Similarities across all countries also arose. Both of the two
high- and middle-income countries most often used academic
journals and conferences as avenues for accessing new evidence,
which is consistent with literature on best practices in evidencebased public health (EBPH), directing readers to academic
journals as the primary avenue for finding relevant evidence
(18). However, as is shown in the literature on barriers to
evidence-based practice, among practitioners who do not have
access to academic journals, the internet is a common, accessible
source for finding evidence (46, 47), which is reflected in
this study’s findings; both high- and middle income countries
frequently cited the internet as a common avenue for accessing
evidence.

(Brazil and China) countries. Practitioners from both highincome countries tended to have more knowledge, access,
and experience, with regard to the implementation of EBCDP,
compared with practitioners from both middle-income
countries.
Practitioners from Brazil and China reported less knowledge
of evidence-based processes than practitioners from Australia
and the United States, with practitioners from China reporting
the least EBCDP knowledge. This finding is consistent with
the literature, citing deficiencies with regard to evidence-based
practice in the field of public health in middle-income regions
of the world, specifically China (36). In China, the lack
of knowledge related to evidence-based processes in chronic
disease prevention may be due to the recent, rapid increase
in chronic disease compared to infectious disease, while still
facing high rates of infectious disease, making it potentially
more difficult to learn and adopt the processes of EBCDP
(37–41).
Also, postgraduate degrees were less common among
practitioners from China and Brazil than among practitioners
from Australia and the United States. For practitioners from
Brazil, one of the most common degrees was a certificate in public
health (less than a bachelor’s degree); whereas consistent with
the structure of the healthcare system in China, practitioners
in this sample tended to have a bachelor’s degree in medicine
and work as physicians in community hospitals. This reflects
the contextual differences between high- and middle-income
countries, of practitioners working in the field of chronic disease
prevention. Additionally, differences in knowledge between both
of the two middle- and high-income countries could be attributed
to the former having larger and better funded institutions that
have the resources to fund, generate, and disseminate research
on EBCDP. Fewer resources can put middle-income countries
at a disadvantage when it comes to supporting the integration
and adoption of evidence-based practices into the field of public
health (42).
Practitioners from China most commonly reported evidencebased repository use by themselves and by colleagues in
few to no programmatic areas. One possible explanation is
the less established nature of EBCDP in China, supported
by a study conducted in China where researchers examined
EBCDP in western countries, to inform EBCDP in China,
finding that the developed western countries had a much larger
evidence base for chronic disease prevention, compared to
China, whose chronic disease prevention evidence base was
behind due to less theoretical guidance and intervention measure
development (43). Further, practitioners with low levels of
knowledge relating to evidence-based processes may not be
aware of how to find relevant repositories of evidence-based
information, or how to use them to attain the information
they need. Moreover, in the United States and Australia,
where repositories were reportedly used more often, other
contextual factors may underlie these patterns. For example,
Australia practitioners report valuing networks as a way of
sharing and learning about new evidence-based initiatives (44).
This information-sharing may contribute to both increased
knowledge of evidence-based processes, and repositories and/or
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This study has several limitations to consider. Because the
types of public health practitioners are not equivalent across
the countries in this study, it is hard to control for this
variable. Additionally, non-random sampling, as carried out
in this study, is susceptible to selection bias, and there may
be distinct differences between those who were selected and
opted to take this study’s survey compared with those who
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were not selected or opted against taking the survey. This
study also did not control for potential confounders like
age, job responsibilities, and culture. While the study did
ask about many of these variables, small cell sizes precluded
multivariable analyses in this study. Future studies should strive
to have a large enough sample size to include all potentially
confounding variables in the analysis. Further, because some
of the chi-square analyses had cells where expected values
were <5, these results should be cautiously interpreted, even
when statistically significant, and a larger, more representative
study of public health practitioners in low-, middle-, and
high- income country is needed, to validate study findings.
Additionally, future studies should conduct country-specific
research on similar variables, to validate findings from this
study, and deepen the evidence-base in this area. Doing so will
enable researchers to better understand, explain, and address the
contextual similarities and differences of practitioner knowledge,
access, and use of EBCDP, among other key contextual
variables.
Additionally, while this study focuses on the value of EBCDP
in reducing chronic disease, the current evidence-base also
supports several limitations of evidence-based practice across
many fields (48–50), which should be acknowledged in this study.
These limitations include a lack of scientific evidence available
to practitioners to inform their practice; research available not
being relevant to the populations that practitioners are serving;
the definition of EBCDP being too narrow and restricting
practices that might prove to be effective for practitioners and
their clients; and the cost of conducting exclusively rigorous
studies to develop an evidence base could be cost prohibitive,
especially for middle- and low-income countries. Therefore,
future studies examining contextual factors that influence
EBCDP knowledge, access, and use across multiple countries
should consider incorporating a broader terminology, such
as evidence-informed decision-making (EIDM), to recognize
the value of multiple types of evidence. Evidence-informed
decision-making is defined as the use of research evidence,
practitioner expertise, existing public health resources, and
knowledge about the local community and political climate,
and promotes practitioners using multiple types of information,
not just scientific evidence, to make comprehensive, informed
decisions to address their clients’ needs (44, 51–53). Further,
it is possible that using EBCDP as the lens for this study,
could explain some of the variances between practitioners
from middle- and high-income countries. Future studies should
consider examining cross-country differences and similarities
across EIDM knowledge, access, and use.

quality improvement process use between the two middle- and
two high-income countries. The distinct differences in EBCDP
among the countries in this study can contribute to informing
and improving global strategies for EBCDP implementation.
Such efforts could take the form of cross-country conferences,
as well as formal and informal partnerships where resources
and knowledge could be shared. Political, administrative,
and stakeholder leaders in these countries can also use these
findings to glean valuable insight into areas that their public
health practitioners need more assistance. Finally, findings
from this study suggest that middle-income countries would
benefit from increased funding, capacity building, and EBCDP
infrastructure, to improve overall practitioner engagement in the
implementation of EBCDP interventions.
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